-
1
-
-
79954576658
-
CD73-deficient mice have increased anti-tumor immunity and are resistant to experimental metastasis
-
Stagg J, Divisekera U, Duret H, Sparwasser T, Teng MW, Darcy PK, et al. CD73-deficient mice have increased anti-tumor immunity and are resistant to experimental metastasis. Cancer Res 2011; 71:2892-900; PMID:21292811; http://dx.doi.org/10.1158/ 0008-5472.CAN-10-4246
-
(2011)
Cancer Res
, vol.71
, pp. 2892-2900
-
-
Stagg, J.1
Divisekera, U.2
Duret, H.3
Sparwasser, T.4
Teng, M.W.5
Darcy, P.K.6
-
2
-
-
75949112218
-
Anti-CD73 antibody therapy inhibits breast cancer tumor growth and metastasis and induces antitumor immunity
-
Stagg J, Divisekera U, McLaughlin N, Sharkey J, Pommey S, Dwyer K, et al. Anti-CD73 antibody therapy inhibits breast cancer tumor growth and metastasis and induces antitumor immunity. Proc Natl Acad Sci USA 2010; 107:1547-52; PMID:20080644; http://dx.doi. org/10.1073/pnas.0908801107
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, pp. 1547-1552
-
-
Stagg, J.1
Divisekera, U.2
McLaughlin, N.3
Sharkey, J.4
Pommey, S.5
Dwyer, K.6
-
3
-
-
77957564570
-
Extracellular adenosine triphosphate and adenosine in cancer
-
Stagg J, Smyth MJ. Extracellular adenosine triphosphate and adenosine in cancer. Oncogene 2010; 29:5346-58; PMID:20661219; http://dx.doi.org/10. 1038/onc.2010.292
-
(2010)
Oncogene
, vol.29
, pp. 5346-5358
-
-
Stagg, J.1
Smyth, M.J.2
-
4
-
-
70350569295
-
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors
-
Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, Ortiz C, et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 2009; 15:1170-8; PMID:19767732; http://dx.doi.org/10.1038/nm.2028
-
(2009)
Nat Med
, vol.15
, pp. 1170-1178
-
-
Ghiringhelli, F.1
Apetoh, L.2
Tesniere, A.3
Aymeric, L.4
Ma, Y.5
Ortiz, C.6
-
5
-
-
33748357735
-
A2A adenosine receptor protects tumors from antitumor T cells
-
Ohta A, Gorelik E, Prasad SJ, Ronchese F, Lukashev D, Wong MK, et al. A2A adenosine receptor protects tumors from antitumor T cells. Proc Natl Acad Sci USA 2006; 103:13132-7; PMID:16916931; http://dx.doi. org/10.1073/pnas.0605251103
-
(2006)
Proc Natl Acad Sci USA
, vol.103
, pp. 13132-13137
-
-
Ohta, A.1
Gorelik, E.2
Prasad, S.J.3
Ronchese, F.4
Lukashev, D.5
Wong, M.K.6
-
6
-
-
77950231071
-
CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression
-
Jin D, Fan J, Wang L, Thompson LF, Liu A, Daniel BJ, et al. CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression. Cancer Res 2010; 70:2245-55; PMID: 20179192; http://dx.doi.org/10.1158/0008-5472.CAN-09-3109
-
(2010)
Cancer Res
, vol.70
, pp. 2245-2255
-
-
Jin, D.1
Fan, J.2
Wang, L.3
Thompson, L.F.4
Liu, A.5
Daniel, B.J.6
-
7
-
-
79957921286
-
CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice
-
Wang L, Fan J, Thompson LF, Zhang Y, Shin T, Curiel T, et al. CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice. J Clin Invest 2011; 121:2371-82; PMID: 21537079; http://dx.doi.org/10.1172/JCI45559
-
(2011)
J Clin Invest
, vol.121
, pp. 2371-2382
-
-
Wang, L.1
Fan, J.2
Thompson, L.F.3
Zhang, Y.4
Shin, T.5
Curiel, T.6
-
8
-
-
79955153842
-
Altered purinergic signaling in CD73-deficient mice inhibits tumor progression
-
Yegutkin GG, Marttila-Ichihara F, Karikoski M, Niemela J, Laurila JP, Elima K, et al. Altered purinergic signaling in CD73-deficient mice inhibits tumor progression. Eur J Immunol 2011; 41:1231-41; PMID: 21469131; http://dx.doi.org/10.1002/eji.201041292
-
(2011)
Eur J Immunol
, vol.41
, pp. 1231-1241
-
-
Yegutkin, G.G.1
Marttila-Ichihara, F.2
Karikoski, M.3
Niemela, J.4
Laurila, J.P.5
Elima, K.6
-
9
-
-
10644240767
-
Crucial role for ecto-5'-nucleotidase (CD73) in vascular leakage during hypoxia
-
Thompson LF, Elzschig HK, Ibla JC, Van De Wiele CJ, Resta R, Morote-Garcia JC, et al. Crucial role for ecto-5'-nucleotidase (CD73) in vascular leakage during hypoxia. J Exp Med 2004; 200:1395-405; PMID:15583013
-
(2004)
J Exp Med
, vol.200
, pp. 1395-1405
-
-
Thompson, L.F.1
Elzschig, H.K.2
Ibla, J.C.3
Van De Wiele, C.J.4
Resta, R.5
Morote-Garcia, J.C.6
-
10
-
-
79551565257
-
NT5E mutations and arterial calcifications
-
St Hilaire C, Ziegler SG, Markello TC, Brusco A, Groden C, Gill F, et al. NT5E mutations and arterial calcifications. N Engl J Med 2011; 364:432-42; PMID: 21288095; http://dx.doi.org/10.1056/NEJMoa0912923
-
(2011)
N Engl J Med
, vol.364
, pp. 432-442
-
-
St Hilaire, C.1
Ziegler, S.G.2
Markello, T.C.3
Brusco, A.4
Groden, C.5
Gill, F.6
|